Rising cases of TB in kids is anticipated to boost growth of global human tuberculosis vaccine market during the predicted timeline. For example, as per a fact sheet reported by the WHO as in October 2021, over 1.1 million kids were examined with TB globally in 2020. Tuberculosis in children is usually overlooked by healthcare suppliers and can be problematic to cure and treat. In 2020, across the globe 30 high tuberculosis burden regions were holding for 86% of new TB case, where eight regions from 30 countries holding for two thirds of the total, with India dominated the count, after China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa.
Global human tuberculosis vaccine market is estimated to be valued at US$ 50.57 Mn in 2022 and is expected to exhibit a CAGR of 4.0% over the forecast period (2022-2030).
To Get a Sample Report with Latest Covid19 Impact Analysis @
Impact of Coronavirus
The most recent epidemic is the coronavirus epidemic, which was primarily identified on December 31, 2019, in Wuhan, China. COVID-19 was announced a pandemic by the WHO on March 11, 2020. As per the WHO Coronavirus Illness Epidemiological Update, coronavirus disease resulted around 528 million cases and 6 million fatalities across the globe, till May 31, 2022.
Moreover, the COVID-19 epidemic is anticipated to have adverse effect on the global human tuberculosis vaccine market growth, due to rising efficiency rate of influenza immunizer for cure of Covid-19 infection over epidemic. For example, in June, 2021, as per the WHO Global TB Report 2021, case notifications have plummeted because of pandemic-related disruptions in healthcare facilities. For the first time in more than a decade, TB fatality has raised. TB fatality have increased because of decreased accessibility to care. In 2020, there were around 1.5 million TB deaths globally, showing the first year-over-year rise in TB deaths since 2005.
Furthermore, key players in market are aiming on growth plans such as collaborations, which is anticipated to fuel market growth during the predicted duration. For example, in July 2021, Biofabri and The International AIDS Vaccine Initiative, aimed on growing immunizers and antibodies against infectious and neglected disorders, collaborated to develop the TB immunizer candidate MTBVAC into efficiency tests
Global human tuberculosis vaccine market is anticipated to show a CAGR of 4.0% over the predicted period, due to rise in the cases of TB. For example, as per data reported by PubMed, a scientific journal, in March 2019, in Argentina, around 9,000 new incidences of tuberculosis are recorded annually, representing a prevailing rate of 22 cases per 100,000 people.
Key players included in the global human tuberculosis vaccine market are Archivel Farma, AJ Vaccines A/S, Japan BCG Laboratory, GlaxoSmithKline Plc, Merck & Co., Inc., Taj Pharma India Limited, GreenSignal Bio Pharma Private Limited (GSBPL), Serum Institute of India Pvt. Ltd., Valneva SE, BIOFABRI (Zendal), and Biomed Lublin S.A.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5209
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Human Tuberculosis Vaccine Market Size Analysis from 2022 to 2030
11.6 COVID-19 Outbreak: Human Tuberculosis Vaccine Industry Impact
Chapter 2 Global Human Tuberculosis Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Human Tuberculosis Vaccine (Volume and Value) by Type
2.3 Global Human Tuberculosis Vaccine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Human Tuberculosis Vaccine Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Human Tuberculosis Vaccine Market Analysis
Chapter 6 East Asia Human Tuberculosis Vaccine Market Analysis
Chapter 7 Europe Human Tuberculosis Vaccine Market Analysis
Chapter 8 South Asia Human Tuberculosis Vaccine Market Analysis
Chapter 9 Southeast Asia Human Tuberculosis Vaccine Market Analysis
Chapter 10 Middle East Human Tuberculosis Vaccine Market Analysis
Chapter 11 Africa Human Tuberculosis Vaccine Market Analysis
Chapter 12 Oceania Human Tuberculosis Vaccine Market Analysis
Chapter 13 South America Human Tuberculosis Vaccine Market Analysis
Chapter 14 Company Profiles and Key Figures in Human Tuberculosis Vaccine Business
Chapter 15 Global Human Tuberculosis Vaccine Market Forecast (2022-2030)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027